The Journal of Organic Chemistry
Note
1
m/z 133.1019. SFC (Chiralpak IG-3, 2.5:97.5 iPrOH:CO2, flow rate
of 1.2 mL/min, λ = 210 nm): tR = 3.44 min [major, (S)-3ha], 3.19
min [minor, (R)-3ha]. Specific rotation: [α]D23 −39.4° (c 0.97, Et2O)
for an enantiomerically enriched sample of 96:4 er. The absolute
configuration was determined by comparison of the sign and the value
of the optical rotation with those reported in the literature for the
to give a greenish oil in 51% yield (28.3 mg). H NMR (500 MHz,
CDCl3): δ 7.36−7.31 (m, 4H), 7.30−7.26 (m, 1H), 4.70 (dd, J = 8.0,
5.5 Hz, 1H), 3.52 (t, J = 5.5 Hz, 2H), 3.36 (t, J = 5.4 Hz, 2H), 2.29 (t,
J = 7.5 Hz, 2H), 2.20 (s, 1H), 1.90−1.58 (m, 6H), 1.56−1.42 (m,
5H), 1.41−1.27 (m, 1H). 13C{1H} NMR (126 MHz, CDCl3): δ
171.3, 145.0, 128.4, 127.4, 125.9, 74.1, 46.7, 42.7, 38.9, 33.2, 26.5,
25.7, 25.6, 25.0, 24.6. HRMS (ESI+-Orbitrap) calcd for C17H24NO:
m/z 258.1852 [M + H − H2O]+, found m/z 258.1857. SFC
(Chiralpak IA-3, 13:87 iPrOH:CO2, flow rate of 1.2 mL/min, λ = 210
nm): tR = 6.79 min [major, (S)-3la], 7.15 min [minor, (R)-3la].
41
25
opposite enantiomer [[α]D +39.3° (c 1.25, Et2O), 94:6].
(S)-2-Cyclohexyl-1-phenylethan-1-ol (3ia). Compound 3ia was
prepared according to the general procedure with (S,S)-me-bipam by
reaction of 2-cyclohexylethan-1-ol (0.25 mmol, 34.9 μL) with phenyl
boronic acid (0.75 mmol, 91.4 mg) and isolated by column
chromatography (silica gel, petroleum ether to petroleum ether/
ethyl acetate 85:15) to give a white amorphous solid in 82% yield
(42.0 mg). The analytical data are consistent with those previously
reported.42 1H NMR (500 MHz, CDCl3): δ 7.37−7.31 (m, 4H),
7.31−7.24 (m, 1H), 4.79 (dd, J = 8.8, 5.1 Hz, 1H), 1.86−1.75 (m,
1H), 1.78−1.48 (m, 7H), 1.46−1.34 (m, 1H), 1.30−1.09 (m, 3H),
1.03−0.86 (m, 2H). 13C{1H} NMR (126 MHz, CDCl3): δ 145.4,
128.5, 127.5, 125.8, 72.1, 47.1, 34.3, 34.0, 32.9, 26.6, 26.3, 26.2.
HRMS (ESI+-Orbitrap) calcd for C14H19: m/z 187.1481 [M + H −
H2O]+, found m/z 187.1438. SFC (Chiralpak IA-3, 5:95 iPrOH:CO2,
flow rate of 1.2 mL/min, λ = 210 nm): tR = 4.15 min [major, (S)-3ia],
23
Specific rotation: [α]D −12.6° (c 1.02, CHCl3) for an enantiomeri-
cally enriched sample of 98:2 er. The absolute configuration was
determined by analogy to compound (S)-3aa.
(S)-N-Cyclohexyl-6-hydroxy-6-phenylhexanamide (3ma). Com-
pound 3ma was prepared according to the general procedure with
(S,S)-me-bipam, except the loading of Ru-2 was doubled, by reaction
of N-cyclohexyl-6-hydroxyhexamide (1m, 0.25 mmol, 53.3 mg) with
phenyl boronic acid (0.75 mmol, 91.4 mg) and isolated by column
chromatography (silica gel, petroleum ether to ethyl acetate) to give a
1
greenish amorphous solid in 55% yield (39.6 mg). H NMR (500
MHz, CDCl3): δ 7.38−7.31 (m, 4H), 7.31−7.23 (m, 1H), 5.24 (d, J =
8.3 Hz, 1H), 4.68 (dd, J = 7.7, 5.6 Hz, 1H), 3.88−3.59 (m, 1H),
2.18−2.06 (m, 2H), 2.04−1.52 (m, 11H), 1.52−1.28 (m, 3H), 1.21−
0.87 (m, 3H). 13C{1H} NMR (126 MHz, CDCl3): δ 171.9, 144.8,
128.5, 127.5, 125.9, 74.3, 48.1, 38.7, 36.9, 33.3, 25.6, 25.5, 25.4, 24.9.
HRMS (ESI+-Orbitrap) calcd for C18H26NO: m/z 272.2009 [M + H
− H2O]+, found m/z 272.2011. SFC (Chiralpak IC-3, 20:80
iPrOH:CO2, flow rate of 1.2 mL/min, λ = 210 nm): tR = 6.69 min
[major, (S)-3ma], 8.15 min [minor, (R)-3ma]. Specific rotation:
[α]D23 −16.8° (c 1.0, CHCl3) for an enantiomerically enriched sample
of 96:4 er. The absolute configuration was determined by analogy to
compound (S)-3aa.
(S)-2-(5-Hydroxy-5-phenylpentyl)isoindoline-1,3-dione (3na).
Compound 3na was prepared according to the general procedure
with (S,S)-me-bipam, except the loading of Ru-2 was doubled, by
reaction of 2-(5-hydroxypentyl)isoindoline-1,3-dione (1n, 0.25 mmol,
58.3 mg) with phenyl boronic acid (0.75 mmol, 91.4 mg) and isolated
by column chromatography (silica gel, petroleum ether to ethyl
acetate) to give a greenish amorphous solid in 49% yield (37.7 mg).
1H NMR (500 MHz, CDCl3): δ 7.87−7.79 (m, 2H), 7.75−7.66 (m,
2H), 7.39−7.29 (m, 4H), 7.29−7.21 (m, 1H), 4.76−4.59 (m, 1H),
3.76−3.58 (m, 2H), 2.02−1.63 (m, 5H), 1.59−1.29 (m, 2H).
13C{1H} NMR (126 MHz, CDCl3): δ 168.5, 144.7, 133.9, 132.1,
128.5, 127.5, 125.8, 123.2, 74.3, 38.5, 37.8, 28.4, 23.1. HRMS (ESI+-
Orbitrap) calcd for C19H18NO2: m/z 292.1332 [M + H − H2O]+,
found m/z 292.1333. SFC (Chiralpak IC-3, 10:90 iPrOH:CO2, flow
rate of 1.2 mL/min, λ = 210 nm): tR = 6.73 min [major, (S)-3na],
23
4.85 min [minor, (R)-3ia]. Specific rotation: [α]D −21.7° (c 1.0,
CHCl3) for an enantiomerically enriched sample of 95:5 er. The
absolute configuration was determined by analogy to compound (S)-
3aa.
(S)-2-(4-Methoxyphenyl)-1-phenylethan-1-ol (3ja). Compound
3ja was prepared according to the general procedure with (S,S)-me-
bipam by reaction of 2-(4-methoxyphenyl)ethan-1-ol (0.25 mmol,
34.6 μL) with phenyl boronic acid (0.75 mmol, 91.4 mg) and isolated
by column chromatography (silica gel, petroleum ether to petroleum
ether/ethyl acetate 85:15) to give a white solid in 44% yield (25.3
mg). The analytical data are consistent with those previously
reported.43 1H NMR (500 MHz, CDCl3): δ 7.38−7.33 (m, 4H),
7.31−7.27 (m, 1H), 7.14−7.08 (m, 2H), 6.88−6.81 (m, 2H), 4.86
(dd, J = 8.5, 4.8 Hz, 1H), 3.80 (s, 3H), 3.03−2.89 (m, 2H), 1.63−
1.46 (br, 1H). 13C{1H} NMR (126 MHz, CDCl3): δ 158.4, 143.9,
130.5, 130.0, 128.4, 127.6, 125.9, 114.0, 75.4, 55.3, 45.2. HRMS
(ESI+-Orbitrap) calcd for C15H15O: m/z 211.1117 [M + H − H2O]+,
found m/z 211.1119. SFC (Chiralpak IH-3, 5:95 iPrOH:CO2, flow
rate of 1.2 mL/min, λ = 210 nm): tR = 5.96 min [major, (S)-3ja], 7.47
min [minor, (R)-3ja]. Specific rotation: [α]D23 −2.8° (c 0.87, CHCl3)
for an enantiomerically enriched sample of 93:7 er. The absolute
configuration was determined by comparison of the sign and the value
of the optical rotation with those reported in the literature for the
43
22
opposite enantiomer [[α]D +3.8° (c 1.4, CHCl3), 94:6].
(S)-Isopropyl 6-Hydroxy-6-phenylhexanoate (3ka). Compound
3ka was prepared according to the general procedure with (S,S)-me-
bipam by reaction of isopropyl 6-hydroxyhexanoate (1k, 0.25 mmol,
43.6 mg) with phenyl boronic acid (0.75 mmol, 91.4 mg) and isolated
by column chromatography (silica gel, petroleum ether to petroleum
ether/ethyl acetate 85:25) to give a white, amorphous solid in 66%
yield (41.1 mg). 1H NMR (500 MHz, CDCl3): δ 7.37−7.32 (m, 4H),
7.31−7.27 (m, 1H), 4.98 (hept, J = 6.3 Hz, 1H), 4.68 (dd, J = 7.6, 5.7
Hz, 1H), 2.25 (t, J = 7.5 Hz, 2H), 1.93−1.78 (m, 1H), 1.73−1.53 (m,
4H), 1.51−1.39 (m, 2H), 1.28−1.17 (m, 6H). 13C{1H} NMR (126
MHz, CDCl3): δ 173.4, 144.8, 128.6, 127.7, 126.0, 74.5, 67.6, 38.8,
34.7, 25.4, 25.0, 22.0. HRMS (ESI+-Orbitrap) calcd for C15H22O2: m/
z 233.1536 [M + H − H2O]+, found m/z 233.1541. SFC (Chiralpak
IC-3, 5:95 iPrOH:CO2, flow rate of 1.2 mL/min, λ = 210 nm): tR =
6.55 min [major, (S)-3ka], 7.24 min [minor, (R)-3ka]. Specific
23
7.13 min [minor, (R)-3na]. Specific rotation: [α]D −14.5° (c 1.0,
CHCl3) for an enantiomerically enriched sample of 97:3 er. The
absolute configuration was determined by analogy to compound (S)-
3aa.
(S)-18-Hydroxy-18-phenyloctadecan-7-one (3oa). Compound
3oa was prepared according to the general procedure with (S,S)-
me-bipam by reaction of 18-hydroxyhexadecan-7-one (1o, 0.13
mmol, 37.0 mg) with phenyl boronic acid (0.39 mmol, 47.6 mg) and
isolated by column chromatography (silica gel, petroleum ether to
petroleum ether/ethyl acetate 85:25) to give a white amorphous solid
1
in 58% yield (27.1 mg). H NMR (500 MHz, CDCl3): δ 7.38−7.31
(m, 4H), 7.30−7.27 (m, 1H), 4.66 (dd, J = 7.6, 5.8 Hz, 1H), 2.37 (td,
J = 7.5, 2.4 Hz, 4H), 2.04−1.62 (m, 2H), 1.67−1.52 (m, 4H), 1.47−
1.37 (m, 1H), 1.34−1.10 (m, 20H), 0.95−0.72 (m, 3H). 13C{1H}
NMR (126 MHz, CDCl3): δ 211.9, 145.0, 128.4, 127.5, 125.9, 74.7,
42.8, 42.8, 39.1, 31.6, 29.5, 29.5, 29.5, 29.4, 29.4, 29.3, 29.0, 25.8,
23.9, 23.9, 22.5, 14.1. HRMS (ESI+-Orbitrap) calcd for C24H39O: m/z
343.2995 [M + H − H2O]+, found m/z 343.2998. SFC (Chiralpak
IA-3, 8.5:91.5 iPrOH:CO2, flow rate of 1.2 mL/min, λ = 210 nm): tR
= 6.41 min [major, (S)-3oa], 6.01 min [minor, (R)-3oa]. Specific
23
rotation: [α]D −19.6° (c 1.02, CHCl3) for an enantiomerically
enriched sample of 95:5 er. The absolute configuration was
determined by analogy to compound (S)-3aa.
Hydroxy-6-phenyl-1-(piperidin-1-yl)hexan-1-one (3la). Com-
pound 3la was prepared according to the general procedure with
(S,S)-me-bipam, except the loading of Ru-2 was doubled, by reaction
of 6-hydroxy-1-(piperidin-1-yl)hexan-1-one (1l, 0.20 mmol, 39.8 mg)
with phenyl boronic acid (0.60 mmol, 73.2 mg) and isolated by
column chromatography (silica gel, petroleum ether to ethyl acetate)
24
rotation: [α]D −12.0° (c 0.99, CHCl3) for an enantiomerically
enriched sample of 97:3 er. The absolute configuration was
determined by analogy to compound (S)-3aa.
9258
J. Org. Chem. 2021, 86, 9253−9262